Tag: Asher Schranz

This year’s ID Week will take place October 19-22, 2025, in Atlanta, GA. ID Week is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists....

Asher Schranz, MD, MPH, and Claire Farel, MD, MPH, discuss the responses to their study, stating that there is diversity in how outpatient parenteral antimicrobial therapy (OPAT) exists and how they are structured. To their knowledge, there is no defined optimal team structure for OPAT, and practice models vary based on clinical...

David Rosen, PhD, MD, and Asher Schranz, MD, MPH, members of the Institute for Global Health and Infectious Diseases, found people with drug use-associated infective endocarditis are at high risk of mortality and future hospitalization for bacterial infections, including endocarditis, skin and soft tissue infections and bacteremia. The study, a...

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations....

Asher Schranz, MD, MPH, assistant professor of medicine in the division of infectious diseases, has received a grant from the NIH National Institute on Drug Abuse for the project “Drug-use associated infective endocarditis: Post-hospitalization outcomes and patient treatment preferences.” Schranz’s research is broadly focused on the intersection of infectious diseases...